In addition, a commercially available dermal filler, hyaluronic acid (HA)-based gel, loaded with CXCL12 was able to recruit and trap CXCR4-expressing B16 melanoma cells injected into mice, consequently leading to a reduction in lung metastases [33]. The gene discussed is CXCR4; the disease is melanoma.